Furthermore, during treatment with the combination of IFN- β and tamoxifen, the expression of several IFN-β-inducible genes was found to be enhanced in human breast carcinoma cell lines relative to levels induced by IFN-β alone [194]. The gene discussed is IFNB1; the disease is breast carcinoma.